Evidence-Based Osteopathy for Tension-Type Headache (EBOTTH) (EBOTTH)
Primary Purpose
Tension-Type Headache
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
osteopathic manipulative treatment
sham
Sponsored by
About this trial
This is an interventional treatment trial for Tension-Type Headache focused on measuring Osteopathic manipulative treatment, Frequent Episodic Tension-Type Headache, Randomized Controlled Trial
Eligibility Criteria
Inclusion Criteria:
- age ≥18 and ≤65 years-old,
- diagnosis of frequent episodic tension-type headache according to the International Headache Society guidelines,
- frequency of attacks ≥3/month,
- willing to adhere to study procedures,
- signed informed consent
Exclusion Criteria:
- age <18 or >65 years-old,
- headache duration less than one year,
- history of: major psychiatric disorders, relevant cognitive deficits, chronic pain other than headache, secondary headaches,
- any type of headache prophylactic treatment ongoing or started during the study,
- hormonal therapy started or modified during the study,
- participating to other clinical trials,
- not willing to sign informed consent
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Osteopathic Manipulative Treatment
Sham Osteopathic Manipulative Treatment
Arm Description
Active manipulative treatment.
Sham manipulative treatment.
Outcomes
Primary Outcome Measures
Headache frequency
average reduction of headache frequency between the two arms and/or over time obtained from the headache diary (n/month)
Secondary Outcome Measures
Headache intensity
average reduction of headache intensity between the two arms and/or over time obtained from the headache diary (average value; scale 0-5)
Symptomatic Drugs
average modification of symptomatic drug use between the two arms and/or over time obtained from the headache diary (n/month)
Headache Disability Inventory (HDI)
average modification of HDI scores between the two arms and/or over time
Headache Impact Test-6 (HIT-6)
average modification of HIT-6 scores between the two arms and/or over time
Side effects
any type of adverse event
Full Information
NCT ID
NCT02592850
First Posted
October 29, 2015
Last Updated
May 31, 2018
Sponsor
University of Milano Bicocca
Collaborators
Italian School of Osteopathy and Manual Therapies, Alpha Search Milano
1. Study Identification
Unique Protocol Identification Number
NCT02592850
Brief Title
Evidence-Based Osteopathy for Tension-Type Headache (EBOTTH)
Acronym
EBOTTH
Official Title
Osteopathic Manipulative Treatment in Frequent Episodic Tension-type Headache: the EBOTTH Multicentric Study
Study Type
Interventional
2. Study Status
Record Verification Date
May 2018
Overall Recruitment Status
Withdrawn
Why Stopped
Problems for satellite centers in obtaining ethical clearance.
Study Start Date
January 2016 (Anticipated)
Primary Completion Date
June 2017 (Anticipated)
Study Completion Date
December 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Milano Bicocca
Collaborators
Italian School of Osteopathy and Manual Therapies, Alpha Search Milano
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Tension-type headache (TTH) is a very common primary headache disorder, with important costs for both patients and society. Often these patients are not willing to take prophylactic medications and resort to complementary therapies. Osteopathic manipulative treatment (OMT) is an interesting option in such field, since it is characterized by a low profile of side effects.
In this study the investigators will assess the efficacy of OMT (semi-structured evaluation and "black box" treatment) in frequent Episodic TTH (ETTH) in an outpatient setting. Preliminary data for power calculation are already available (Rolle et al. 2014), and the investigators plan to recruit 264 ETHH patients by a multicentric, randomized, double-blind, sham-controlled design.
Detailed Description
Background:
Primary headache disorders are very common throughout the world, producing widespread and substantial disability and representing a concrete public-health priority. Tension-type headache (TTH) is the most common type of primary headache disorder, with a lifetime prevalence in the general population ranging between 30% and 78% in different studies. In general, headache is a chronic disorder with episodic manifestations that may range from few attacks/year up to daily episodes. Its impact on individuals' lives is greater than has generally been realized, including psychiatric, psychological and social correlates. The impact on patients can be very high, including ictal symptom burden, interictal burden, cumulative burden and impact on other people. The individual burden of TTH includes both symptoms occurring during the attacks (pain, eventually accompanied by no more than one of phonophobia or photophobia, according to International Classification of Headache Disorders) and elements of interictal burden, such as anxiety, mood disorders, affective distress and avoidance behavior. While present, symptoms may cause debility and prostration, and reduce functional ability. Even if patients with TTH generally are not unable to work, effectiveness and productivity may be consistently reduced. This secondary disability is quite significant because headache in general is most common in people between their teens and 50-60 years of age, the productive years. The elements of interictal burden, instead, may continuously affect wellbeing and impair quality of life. Moreover, TTH has a substantial impact on the health system, due to both direct and indirect financial cost. The high prevalence of TTH, considering its individual impact and huge financial costs, has important implications for health policy, since it is a source of high but potentially reducible socioeconomic burden. Essentially, TTH management is a public-health priority.
On the clinical side, tension-type headache has been defined as a multifactorial disorder, conceivably implying the need for tailored treatment strategies. Headache-related disability can usually be reduced by identifying and avoiding triggers combined with pharmacologic and non-pharmacologic treatment (such as relaxation and stress management techniques or physical therapies), but effective treatment modalities are still lacking. Particularly, symptomatic drugs are effective for episodes of TTH, whereas preventive treatment (indicated for frequent and chronic TTH) is, on average, barely effective, and do not display good tolerability. Patients are turning to complementary or alternative therapies for headaches, including osteopathic manipulative therapy (OMTh). One previous pilot study carried out by the investigators has suggested an efficacy for OMTh in frequent episodic TTH, that might represent an alternative treatment strategy to prophylactic drugs. Frequent episodic TTH (ETTH) was chosen for this study since it is the most common diagnostic category with indications for prophylactic drug management. To date there is no rigorously tested evidence that manual therapies in general have a positive effect on TTH, as many reviewers have found. Conflicting results in previous studies might be due both to the low number of clinical trials and an indiscriminate application of different techniques. Some studies, however, have demonstrated positive effects of manipulative therapy.
A systematic review found spinal manipulative therapy as effective as commonly used first-line prophylactic medications for both TTH and migraine headaches, but the Authors emphasized that their conclusions were based on only a few trials, raising the question of whether their analysis was methodologically adequate. A more recent systematic review concluded that spinal manipulation might alleviate TTH but that the small quantity of available data prevented any definitive conclusions. The combination of physical therapies with medications, can also increase the success of the treatment, particularly in case of comorbid mood disorders and unremitting headaches, as previously suggested. Although results of these and others published studies suggest positive effects, OMTh has rarely been rigorously tested for the care of patients with headache in general.
OMTh is not free of costs but is plausibly characterized by fewer contraindications and adverse events than conventional pharmacological treatments, and particularly indicated for patients not compliant with drug regimens and those at increased risk of adverse drug effects. Notably, there is disparity between patient perceptions and clinical definitions of adverse events, as a conceptual model with four inter-related components (expectation, personal investment, osteopathic encounter and clinical change) has suggested. Patients might report mild effects following OMTh and in general all forms of manual therapy, but these effects should not be strictly regarded as adverse events. Our previous pilot trial did not observe adverse events among ETTH patients belonging to both arms of the study (treatment and sham). Exceedingly rare serious adverse events may be observed after spine manipulation, only one of many different techniques usually administered in osteopathic clinical field and recommendations have been already published to meet the requirements of the principles of prevention and precaution. For example, minor unwanted effects of prior manipulation should be searched routinely and taken as contraindication for future spinal manipulations. Great care should be taken when particular anatomic conditions such as cord encroachment or increased vertebra-basilar risk are present. Certainly, besides effectiveness, still to be completely proven, the financial impact of OMTh on subjects and health systems could be also a topic of appraisal for future comparative studies.
However, considering all the exposed priorities in this field, the investigators decided to firstly address in a RCT the question of OMTh efficacy versus OMTh-sham treatment in ETTH.
Aims:
This is a protocol for a randomized controlled trial (RCT) exploring the efficacy of OMTh in ETTH with respect to OMTh-sham treatment by a single blinded multicenter design.
If OMTh effectiveness could be demonstrated in these patients, two putative repercussions in ETTH management might be expected: (a) increased compliance; (b) lower rate of side effects. Furthermore, OMTh would increase the range of available strategies for managing ETTH in clinical practice, perhaps even as an add-on therapy.
Study Design:
This is a multi-centre, double-blinded, randomized, sham-treatment (SHAM)-controlled study using an experimental design.
Presumed ETTH patients will be screened at pre-selected primary care settings (general practitioners), and the diagnosis of TTH reviewed (time -30, or T-30) by a neurologist that will ask patients to complete the headache diary for 30 days before randomization. Diaries will be reviewed at time 0 (T0; baseline) by a blind-rater D.O. that will decide if the number of attacks is compatible with the diagnosis of ETTH, allowing randomization. The blind-rater will perform an osteopathic structural examination that will compulsory include (semi-structured evaluation) also the assessment of temporo-mandibular joint disorders and cervical dysfunctions (TMJD and CD) in order to define putative goals of OMT that will be used for scoring a Goal Attainment Scale (GAS, see below Outcomes) without involving the treating D.O. that will operate independently. Furthermore, patients will be asked to complete the Headache Disability Inventory (HDI) and the Headache Impact Test-6 (HIT-6).
Randomization will be performed by the coordinating centre (Univ. of Milano-Bicocca, Italy) by randomly pre-generated lists; the coordinating centre, without informing the blind-rater, will communicate to the local Osteopathic Clinic these details. Patients will be given instructions to start treatment (OMT vs. SHAM in blind) that will be administered by a treating D.O. unblinded to treatment allocation. Patients will receive 4 weekly treatments completing the headache diary along the whole study (up to T120). The blind-rater will review diaries relative to the each previous period and ask patients to complete the HDI/HIT-6 at 30 days (T30, end of treatment), 60 days (T60, follow-up-1), 90 days (T90, follow-up-2) and 120 days (T120, end of study) with respect to randomization (T0). An osteopathic structural examination will be performed again at T120 (end of study) for GAS scoring. A central database will be filled.
Inclusion criteria will be: (1) a diagnosis of ETTH according to current International Headache Society guidelines; (2) willing to comply with the RCT procedures.
Exclusion criteria will be: (1) patients under 18 or over 65 years of age; (2) use during the previous three months of drugs for acute headache on ten or more days per month; (3) duration of disease less than one year; (4) history of major psychiatric diseases, significant cognitive disorders, significant chronic pain other than headache, or in general from a secondary headache; (5) any kind of ongoing prophylactic treatment or taking place during the whole study period; (6) estroprogestinic therapy started or modified during the whole study period.
Patients will be blindly allocated to (A) an experimental arm (OMT) and (B) a control arm (SHAM), i.e., manual perceptive technique without correction of any observed osteopathic disorder. In order to minimize the perceived differences, both groups will undergo to osteopathic structural examination, with a similar amount of time being spent on each session. OMT will not be protocol-based but the treating D.O. will compulsory have to include the evaluation (and possible treatment) of TMJD and CD (semi-structured treatment). Specifically, OMT will focus on correcting those osteopathic dysfunctions found during the initial evaluation; both structural (including myofascial release and HVLA), visceral and craniosacral techniques will be administered as appropriate. As regards the sham treatment, the operator will be restricted to the assessment of the cranial rhythmic impulse (CRI) in patients, spending a similar amount of time to that being spent on OMT-treated patients.
Primary outcome will be the change at T120 in patient-reported headache frequency of at least 30% with respect to the control group (based on the previous pilot study, Rolle et al. 2014). Secondary outcomes will include: (a) any significant reduction over time or with respect to the control group of the average headache intensity based on a scale between 0 (absence of pain) and 5 (worst perceived pain) (considered more sensible with respect to a 0-to-3 scale, see Rolle et al. 2014); (b) any significant reduction over time or with respect to the control group of the over-the-counter medication usage; (c) any significant reduction over time or with respect to the control group of the HDI/HIT-6 scores; (d) any significant reduction over time or with respect to the control group in patient-reported headache frequency. Tertiary outcome will be: any significant reduction over time or with respect to the control group of the blind-rater evaluation of the osteopathic effects of the whole treatment with respect to the attainments he initially proposed. This score will be assessed purely in terms of correction of those osteopathic dysfunctions that were detected at T0, by using the GAS, with a five-point score ranging from: -2 (much less than expected outcome), to -1 (less than expected outcome), to 0 (expected outcome reached), to +1 (greater than expected outcome), to +2 (much greater than expected outcome).
Finally, side effects will be recorded at each visit. Patients will be instructed to immediately report serious adverse effects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tension-Type Headache
Keywords
Osteopathic manipulative treatment, Frequent Episodic Tension-Type Headache, Randomized Controlled Trial
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Osteopathic Manipulative Treatment
Arm Type
Experimental
Arm Description
Active manipulative treatment.
Arm Title
Sham Osteopathic Manipulative Treatment
Arm Type
Sham Comparator
Arm Description
Sham manipulative treatment.
Intervention Type
Other
Intervention Name(s)
osteopathic manipulative treatment
Other Intervention Name(s)
OMT
Intervention Description
This intervention will not be protocol-based but the treating D.O. will compulsory have to include the evaluation (and possible treatment) of temporo-mandibular joint disorders and cervical dysfunctions (semi-structured treatment). Specifically, OMT will focus on correcting those osteopathic dysfunctions found during the initial evaluation; both structural (including myofascial release and HVLA), visceral and craniosacral techniques will be administered as appropriate.
Duration: 45 minutes. Administered once a week for four weeks.
Intervention Type
Other
Intervention Name(s)
sham
Other Intervention Name(s)
SHAM-OMT
Intervention Description
In this intervention, the operator will be restricted to the assessment of the cranial rhythmic impulse (CRI), temporo-mandibular joint disorders and cervical dysfunctions, spending a similar amount of time to that being spent on OMT-treated patients. Any found osteopathic dysfunction will not be corrected.
Duration: 45 minutes. Administered once a week for four weeks.
Primary Outcome Measure Information:
Title
Headache frequency
Description
average reduction of headache frequency between the two arms and/or over time obtained from the headache diary (n/month)
Time Frame
4 months
Secondary Outcome Measure Information:
Title
Headache intensity
Description
average reduction of headache intensity between the two arms and/or over time obtained from the headache diary (average value; scale 0-5)
Time Frame
4 months
Title
Symptomatic Drugs
Description
average modification of symptomatic drug use between the two arms and/or over time obtained from the headache diary (n/month)
Time Frame
4 months
Title
Headache Disability Inventory (HDI)
Description
average modification of HDI scores between the two arms and/or over time
Time Frame
4 months
Title
Headache Impact Test-6 (HIT-6)
Description
average modification of HIT-6 scores between the two arms and/or over time
Time Frame
4 months
Title
Side effects
Description
any type of adverse event
Time Frame
4 months
Other Pre-specified Outcome Measures:
Title
Goal Attainment Scale (GAS) for osteopathic dysfunction
Description
any modification of any osteopathic dysfunction found at study entry between the two arms and/or over time (score between -2 and +2)
Time Frame
4 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age ≥18 and ≤65 years-old,
diagnosis of frequent episodic tension-type headache according to the International Headache Society guidelines,
frequency of attacks ≥3/month,
willing to adhere to study procedures,
signed informed consent
Exclusion Criteria:
age <18 or >65 years-old,
headache duration less than one year,
history of: major psychiatric disorders, relevant cognitive deficits, chronic pain other than headache, secondary headaches,
any type of headache prophylactic treatment ongoing or started during the study,
hormonal therapy started or modified during the study,
participating to other clinical trials,
not willing to sign informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lucio Tremolizzo, MD, PhD
Organizational Affiliation
University of Milano-Bicocca, Italy
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Guido Rolle, DO, MD
Organizational Affiliation
Italian School of Osteopathy and Manual Therapies
Official's Role
Study Director
12. IPD Sharing Statement
Citations:
PubMed Identifier
17381554
Citation
Stovner Lj, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007 Mar;27(3):193-210. doi: 10.1111/j.1468-2982.2007.01288.x.
Results Reference
background
PubMed Identifier
18339350
Citation
Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008 Apr;7(4):354-61. doi: 10.1016/S1474-4422(08)70062-0.
Results Reference
background
PubMed Identifier
9459472
Citation
Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA. 1998 Feb 4;279(5):381-3. doi: 10.1001/jama.279.5.381.
Results Reference
background
PubMed Identifier
1941010
Citation
Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol. 1991;44(11):1147-57. doi: 10.1016/0895-4356(91)90147-2.
Results Reference
background
PubMed Identifier
16643310
Citation
Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol. 2006 Apr;13(4):333-45. doi: 10.1111/j.1468-1331.2006.01184.x.
Results Reference
background
PubMed Identifier
16702836
Citation
Stovner LJ, Hagen K. Prevalence, burden, and cost of headache disorders. Curr Opin Neurol. 2006 Jun;19(3):281-5. doi: 10.1097/01.wco.0000227039.16071.92.
Results Reference
background
PubMed Identifier
20473702
Citation
Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010 Aug;11(4):289-99. doi: 10.1007/s10194-010-0217-0. Epub 2010 May 16.
Results Reference
background
PubMed Identifier
14604504
Citation
Jensen R. Diagnosis, epidemiology, and impact of tension-type headache. Curr Pain Headache Rep. 2003 Dec;7(6):455-9. doi: 10.1007/s11916-003-0061-x.
Results Reference
background
PubMed Identifier
10759896
Citation
Holroyd KA, Stensland M, Lipchik GL, Hill KR, O'Donnell FS, Cordingley G. Psychosocial correlates and impact of chronic tension-type headaches. Headache. 2000 Jan;40(1):3-16. doi: 10.1046/j.1526-4610.2000.00001.x.
Results Reference
background
PubMed Identifier
20108021
Citation
Beghi E, Bussone G, D'Amico D, Cortelli P, Cevoli S, Manzoni GC, Torelli P, Tonini MC, Allais G, De Simone R, D'Onofrio F, Genco S, Moschiano F, Beghi M, Salvi S. Headache, anxiety and depressive disorders: the HADAS study. J Headache Pain. 2010 Apr;11(2):141-50. doi: 10.1007/s10194-010-0187-2. Epub 2010 Jan 27.
Results Reference
background
PubMed Identifier
24884549
Citation
Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lanteri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Barre J, Andree C. The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain. 2014 May 21;15(1):31. doi: 10.1186/1129-2377-15-31.
Results Reference
background
PubMed Identifier
23771276
Citation
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013 Jul;33(9):629-808. doi: 10.1177/0333102413485658. No abstract available.
Results Reference
background
PubMed Identifier
17087872
Citation
Lenaerts ME. Burden of tension-type headache. Curr Pain Headache Rep. 2006 Dec;10(6):459-62. doi: 10.1007/s11916-006-0078-z.
Results Reference
background
PubMed Identifier
22136117
Citation
Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barre J, Katsarava Z, Lainez JM, Lampl C, Lanteri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andree C. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012 May;19(5):703-11. doi: 10.1111/j.1468-1331.2011.03612.x. Epub 2011 Dec 5.
Results Reference
background
PubMed Identifier
21247362
Citation
Bendtsen L, Jensen R. Treating tension-type headache -- an expert opinion. Expert Opin Pharmacother. 2011 May;12(7):1099-109. doi: 10.1517/14656566.2011.548806. Epub 2011 Jan 20.
Results Reference
background
PubMed Identifier
19289230
Citation
Bendtsen L, Jensen R. Tension-type headache. Neurol Clin. 2009 May;27(2):525-35. doi: 10.1016/j.ncl.2008.11.010.
Results Reference
background
PubMed Identifier
18093564
Citation
Fumal A, Schoenen J. Tension-type headache: current research and clinical management. Lancet Neurol. 2008 Jan;7(1):70-83. doi: 10.1016/S1474-4422(07)70325-3.
Results Reference
background
PubMed Identifier
19807317
Citation
Jensen R, Rasmussen BK. Burden of headache. Expert Rev Pharmacoecon Outcomes Res. 2004 Jun;4(3):353-9. doi: 10.1586/14737167.4.3.353.
Results Reference
background
PubMed Identifier
24867829
Citation
Barbanti P, Egeo G, Aurilia C, Fofi L. Treatment of tension-type headache: from old myths to modern concepts. Neurol Sci. 2014 May;35 Suppl 1:17-21. doi: 10.1007/s10072-014-1735-3.
Results Reference
background
PubMed Identifier
21845469
Citation
Mathew PG, Mathew T. Taking care of the challenging tension headache patient. Curr Pain Headache Rep. 2011 Dec;15(6):444-50. doi: 10.1007/s11916-011-0223-1.
Results Reference
background
PubMed Identifier
25170037
Citation
Rolle G, Tremolizzo L, Somalvico F, Ferrarese C, Bressan LC. Pilot trial of osteopathic manipulative therapy for patients with frequent episodic tension-type headache. J Am Osteopath Assoc. 2014 Sep;114(9):678-85. doi: 10.7556/jaoa.2014.136.
Results Reference
background
PubMed Identifier
16514329
Citation
Fernandez-de-Las-Penas C, Alonso-Blanco C, Cuadrado ML, Miangolarra JC, Barriga FJ, Pareja JA. Are manual therapies effective in reducing pain from tension-type headache?: a systematic review. Clin J Pain. 2006 Mar-Apr;22(3):278-85. doi: 10.1097/01.ajp.0000173017.64741.86.
Results Reference
background
PubMed Identifier
16596892
Citation
Fernandez-de-las-Penas C, Alonso-Blanco C, San-Roman J, Miangolarra-Page JC. Methodological quality of randomized controlled trials of spinal manipulation and mobilization in tension-type headache, migraine, and cervicogenic headache. J Orthop Sports Phys Ther. 2006 Mar;36(3):160-9. doi: 10.2519/jospt.2006.36.3.160.
Results Reference
background
PubMed Identifier
17549233
Citation
Tsao JC. Effectiveness of massage therapy for chronic, non-malignant pain: a review. Evid Based Complement Alternat Med. 2007 Jun;4(2):165-79. doi: 10.1093/ecam/nel109. Epub 2007 Feb 5.
Results Reference
background
PubMed Identifier
15561394
Citation
Lenssinck MB, Damen L, Verhagen AP, Berger MY, Passchier J, Koes BW. The effectiveness of physiotherapy and manipulation in patients with tension-type headache: a systematic review. Pain. 2004 Dec;112(3):381-388. doi: 10.1016/j.pain.2004.09.026.
Results Reference
background
PubMed Identifier
12383058
Citation
Astin JA, Ernst E. The effectiveness of spinal manipulation for the treatment of headache disorders: a systematic review of randomized clinical trials. Cephalalgia. 2002 Oct;22(8):617-23. doi: 10.1046/j.1468-2982.2002.00423.x.
Results Reference
background
PubMed Identifier
18494995
Citation
Fernandez-de-Las-Penas C. Physical therapy and exercise in headache. Cephalalgia. 2008 Jul;28 Suppl 1:36-8. doi: 10.1111/j.1468-2982.2008.01618.x.
Results Reference
background
PubMed Identifier
12221344
Citation
Jull G, Trott P, Potter H, Zito G, Niere K, Shirley D, Emberson J, Marschner I, Richardson C. A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache. Spine (Phila Pa 1976). 2002 Sep 1;27(17):1835-43; discussion 1843. doi: 10.1097/00007632-200209010-00004.
Results Reference
background
PubMed Identifier
14687010
Citation
Torelli P, Jensen R, Olesen J. Physiotherapy for tension-type headache: a controlled study. Cephalalgia. 2004 Jan;24(1):29-36. doi: 10.1111/j.1468-2982.2004.00633.x.
Results Reference
background
PubMed Identifier
24785463
Citation
Espi-Lopez GV, Rodriguez-Blanco C, Oliva-Pascual-Vaca A, Benitez-Martinez JC, Lluch E, Falla D. Effect of manual therapy techniques on headache disability in patients with tension-type headache. Randomized controlled trial. Eur J Phys Rehabil Med. 2014 Dec;50(6):641-7. Epub 2014 Apr 30.
Results Reference
background
PubMed Identifier
11562654
Citation
Bronfort G, Assendelft WJ, Evans R, Haas M, Bouter L. Efficacy of spinal manipulation for chronic headache: a systematic review. J Manipulative Physiol Ther. 2001 Sep;24(7):457-66.
Results Reference
background
PubMed Identifier
22579436
Citation
Posadzki P, Ernst E. Spinal manipulations for tension-type headaches: a systematic review of randomized controlled trials. Complement Ther Med. 2012 Aug;20(4):232-9. doi: 10.1016/j.ctim.2011.12.001. Epub 2011 Dec 29.
Results Reference
background
PubMed Identifier
18973739
Citation
Sun-Edelstein C, Mauskop A. Complementary and alternative approaches to the treatment of tension-type headache. Curr Pain Headache Rep. 2008 Dec;12(6):447-50. doi: 10.1007/s11916-008-0076-4.
Results Reference
background
PubMed Identifier
581588
Citation
Hoyt WH, Shaffer F, Bard DA, Benesler JS, Blankenhorn GD, Gray JH, Hartman WT, Hughes LC. Osteopathic manipulation in the treatment of muscle-contraction headache. J Am Osteopath Assoc. 1979 Jan;78(5):322-5. No abstract available.
Results Reference
background
PubMed Identifier
21943616
Citation
Ajimsha MS. Effectiveness of direct vs indirect technique myofascial release in the management of tension-type headache. J Bodyw Mov Ther. 2011 Oct;15(4):431-5. doi: 10.1016/j.jbmt.2011.01.021. Epub 2011 Feb 11.
Results Reference
background
PubMed Identifier
21385086
Citation
Voigt K, Liebnitzky J, Burmeister U, Sihvonen-Riemenschneider H, Beck M, Voigt R, Bergmann A. Efficacy of osteopathic manipulative treatment of female patients with migraine: results of a randomized controlled trial. J Altern Complement Med. 2011 Mar;17(3):225-30. doi: 10.1089/acm.2009.0673. Epub 2011 Mar 8.
Results Reference
background
PubMed Identifier
16942472
Citation
Anderson RE, Seniscal C. A comparison of selected osteopathic treatment and relaxation for tension-type headaches. Headache. 2006 Sep;46(8):1273-80. doi: 10.1111/j.1526-4610.2006.00535.x.
Results Reference
background
PubMed Identifier
22425134
Citation
Rajendran D, Bright P, Bettles S, Carnes D, Mullinger B. What puts the adverse in 'adverse events'? Patients' perceptions of post-treatment experiences in osteopathy--a qualitative study using focus groups. Man Ther. 2012 Aug;17(4):305-11. doi: 10.1016/j.math.2012.02.011. Epub 2012 Mar 15.
Results Reference
background
PubMed Identifier
18586346
Citation
Tinel D, Bliznakova E, Juhel C, Gallien P, Brissot R. Vertebrobasilar ischemia after cervical spine manipulation: a case report. Ann Readapt Med Phys. 2008 Jun;51(5):403-14. doi: 10.1016/j.annrmp.2008.04.010. Epub 2008 May 28. English, French.
Results Reference
background
PubMed Identifier
24402084
Citation
Cicconi M, Mangiulli T, Bolino G. Onset of complications following cervical manipulation due to malpractice in osteopathic treatment: a case report. Med Sci Law. 2014 Oct;54(4):230-3. doi: 10.1177/0025802413513451. Epub 2014 Jan 8.
Results Reference
background
PubMed Identifier
7751168
Citation
Greenman PE, McPartland JM. Cranial findings and iatrogenesis from craniosacral manipulation in patients with traumatic brain syndrome. J Am Osteopath Assoc. 1995 Mar;95(3):182-8; 191-2.
Results Reference
background
PubMed Identifier
15959358
Citation
Suh SI, Koh SB, Choi EJ, Kim BJ, Park MK, Park KW, Yoon JS, Lee DH. Intracranial hypotension induced by cervical spine chiropractic manipulation. Spine (Phila Pa 1976). 2005 Jun 15;30(12):E340-2. doi: 10.1097/01.brs.0000166511.59868.b7.
Results Reference
background
PubMed Identifier
23787298
Citation
Hebert JJ, Stomski NJ, French SD, Rubinstein SM. Serious Adverse Events and Spinal Manipulative Therapy of the Low Back Region: A Systematic Review of Cases. J Manipulative Physiol Ther. 2015 Nov-Dec;38(9):677-691. doi: 10.1016/j.jmpt.2013.05.009. Epub 2013 Jun 17.
Results Reference
background
PubMed Identifier
15083985
Citation
Noll DR, Degenhardt BF, Stuart M, McGovern R, Matteson M. Effectiveness of a sham protocol and adverse effects in a clinical trial of osteopathic manipulative treatment in nursing home patients. J Am Osteopath Assoc. 2004 Mar;104(3):107-13. No abstract available.
Results Reference
background
PubMed Identifier
10963073
Citation
Vautravers P, Maigne JY. Cervical spine manipulation and the precautionary principle. Joint Bone Spine. 2000;67(4):272-6.
Results Reference
background
PubMed Identifier
14710030
Citation
Vautravers P, Maigne JY. [Cervical spine manipulation: risks--benefit--assessment]. Rev Neurol (Paris). 2003 Nov;159(11):1064-6. French.
Results Reference
background
PubMed Identifier
16584950
Citation
Murphy DR, Hurwitz EL, Gregory AA. Manipulation in the presence of cervical spinal cord compression: a case series. J Manipulative Physiol Ther. 2006 Mar-Apr;29(3):236-44. doi: 10.1016/j.jmpt.2006.01.001.
Results Reference
background
PubMed Identifier
15965410
Citation
Cagnie B, Barbaix E, Vinck E, D'Herde K, Cambier D. A case of abnormal findings in the course of the vertebral artery associated with an ossified hyoid apparatus. A contraindication for manipulation of the cervical spine? J Manipulative Physiol Ther. 2005 Jun;28(5):346-51. doi: 10.1016/j.jmpt.2005.04.007.
Results Reference
background
Learn more about this trial
Evidence-Based Osteopathy for Tension-Type Headache (EBOTTH)
We'll reach out to this number within 24 hrs